The pharmaceutical, biotech and medical device businesses are facing major challenges.
Reorganising their business models, boosting R&D productivity, optimising manufacturing and restructuring their sales forces and more. Stakeholders such as shareholders, physicians, patients, payers and regulators are exerting pressure for change.
© 2016 - Thu Oct 19 04:19:34 EDT 2017 PwC. All rights reserved. PwC refers to the PwC network and/or one or more of its member firms, each of which is a separate legal entity. Please see www.pwc.com/structure for further details.